Literature DB >> 9873730

Potent inhibitors of the MAP kinase p38.

J R Henry1, K C Rupert, J H Dodd, I J Turchi, S A Wadsworth, D E Cavender, P H Schafer, J J Siekierka.   

Abstract

The MAP kinase p38 plays a key role in the biosynthesis of the inflammatory cytokines TNF-alpha and IL-1. We have developed a novel series of potent p38 inhibitors that could lead to new methods of treatment for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873730     DOI: 10.1016/s0960-894x(98)00589-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

2.  Selection and separation of viable cells based on a cell-lethal assay.

Authors:  Wei Xu; Annadele Herman; Colleen Phillips; Jeng-Hao Pai; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2010-12-13       Impact factor: 6.986

Review 3.  Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.

Authors:  Alexandros A Drosos
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Construction of 4D-QSAR models for use in the design of novel p38-MAPK inhibitors.

Authors:  Nelilma Correia Romeiro; Magaly Girão Albuquerque; Ricardo Bicca de Alencastro; Malini Ravi; Anton J Hopfinger
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

5.  SD0006: a potent, selective and orally available inhibitor of p38 kinase.

Authors:  Barry L Burnette; Shaun Selness; Raj Devraj; Gail Jungbluth; Ravi Kurumbail; Loreen Stillwell; Gary Anderson; Stephen Mnich; Jeffrey Hirsch; Robert Compton; Pamela De Ciechi; Heidi Hope; Michael Hepperle; Robert H Keith; Win Naing; Huey Shieh; Joseph Portanova; Yan Zhang; Jian Zhang; Richard M Leimgruber; Joseph Monahan
Journal:  Pharmacology       Date:  2009-07-04       Impact factor: 2.547

6.  Synthesis and Biological Screening of Pyrano[3,2-c]quinoline Analogues as Anti-inflammatory and Anticancer Agents.

Authors:  Kuldip D Upadhyay; Narsinh M Dodia; Rupesh C Khunt; Ravi S Chaniara; Anamik K Shah
Journal:  ACS Med Chem Lett       Date:  2018-02-23       Impact factor: 4.345

7.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

8.  Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.

Authors:  Nelilma Correia Romeiro; Magaly Girão Albuquerque; Ricardo Bicca de Alencastro; Malini Ravi; Anton J Hopfinger
Journal:  J Mol Model       Date:  2006-03-16       Impact factor: 1.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.